Axsome Therapeutics
Axsome Therapeutics Logo
About Axsome Therapeutics
Axsome Therapeutics Inc is a biopharmaceutical company focused on developing and delivering novel therapies for central nervous system (CNS) disorders. The company's commercial portfolio includes Auvelity for major depressive disorder, Sunosi for excessive daytime sleepiness in narcolepsy or obstructive sleep apnea, and Symbravo (AXS-07) for acute migraine treatment. Axsome is also advancing a pipeline of investigational therapies, including AXS-05 for Alzheimer's disease agitation and smoking cessation, AXS-12 for narcolepsy, AXS-14 for fibromyalgia, and solriamfetol for additional indications such as attention deficit hyperactivity disorder and binge eating disorder. The company is committed to improving patient outcomes in CNS conditions through innovative science and research.
Address
One World Trade Center, 22nd Floor
New York, 10007
United States
Year founded
2012
Number of employees
600-700
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
